Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.18B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: YELP stock price vs BNTX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BNTX's multiple
Needs BNTX P/E.
Implied fair value · at YELP's multiple
Needs EPS (TTM) is negative, YELP P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: YELP FY 2025 (ended Dec 31, 2025) · BNTX FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 104% equity / -4% debt · EV / Revenue 0.56x · EV / EBITDA 3.15x
Capital structure 91% equity / 9% debt · EV / Revenue 6.07x
BNTX carries the larger enterprise value at $20.26B against $813.44M; YELP trades on the lower EV / Revenue multiple (0.56x vs 6.07x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
YELP INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
BioNTech SE · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-0.06x
—
Net debt / EBITDA
Leverage against operating earnings
-1.40x
4.45x
Cash and equivalents
Liquid reserves on the balance sheet
$319.35M
$7.68B
Total debt
Interest-bearing obligations outstanding
-$42.56M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TripAdvisor, Inc.
YELP vs TRIP
Booking Holdings Inc.
YELP vs BKNG
Expedia Group, Inc.
YELP vs EXPE
Match Group, Inc.
YELP vs MTCH
Moderna, Inc.
YELP vs MRNA
GILEAD SCIENCES, INC.
YELP vs GILD
AMGEN INC
YELP vs AMGN
REGENERON PHARMACEUTICALS, INC.
YELP vs REGN
INCYTE CORP
YELP vs INCY
VERTEX PHARMACEUTICALS INC / MA
YELP vs VRTX
$2.68B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
